ArticleInvestigative and clinical urology2018
Short-term outcomes of the transvaginal minimal mesh procedure for pelvic organ prolapse.
Article in Investigative and clinical urology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- Postoperative Reduction in Postvoid Residual Urine Volume May Be Associated With Bladder Capacity Decrease Rather Than an Increase in Tidal Voided Urine Volume in Patients With Pelvic Organ Prolapse.The journal of obstetrics and gynaecology research · 2026Article
- Pelvic Floor Reconstruction Using Mesh Versus Campbell Uterosacral Ligament Suspension: 2-Year Clinical Outcome.International urogynecology journal · 2026Article
- Transvaginal Mesh Surgery Is Sufficient to Repair Pelvic Organ Prolapse Compared to Laparoscopic Sacrocolpopexy: A Propensity Score Matching Analysis.International neurourology journal · 2025Article
- Failure to Adjust Mesh Length Beneath the Bladder Is an Independent Factor of Postoperative Urinary Incontinence After Transvaginal Mesh Surgery.International neurourology journal · 2025Article
- Article
- Safety and Effectiveness of G-MeshJournal of clinical medicine · 2024Article
- Favorable Postoperative Outcomes After Transvaginal Mesh Surgery Using a Wide-Arm ORIHIME® Mesh.Cureus · 2024Article
- Association between overactive bladder and pelvic organ mobility as evaluated by dynamic magnetic resonance imaging.Scientific reports · 2021Article
- Comparison of Postoperative Voiding and Storage Function Following Laparoscopic Sacrocolpopexy and Transvaginal Mesh Surgery Using Nearest-neighbor Propensity Score Matching Analysis.Gynecology and minimally invasive therapyArticle
- Prolapse Quality-of-life Questionnaire is a Reliable Postoperative Outcome Assessment.Gynecology and minimally invasive therapyArticle
- Comparison of Postoperative Urinary Storage Function Following Laparoscopic Sacrocolpopexy and Transvaginal Mesh Surgery Using Nearest-neighbor Propensity Score Matching Analysis.Journal of mid-life healthArticle
- Vesicovaginal Adhesion as an Independent Factor of Postoperative Recurrence after Laparoscopic Sacrocolpopexy.Gynecology and minimally invasive therapyArticle
- Article
- A Comparison of the Postoperative Outcomes of Laparoscopic Sacrocolpopexy and Transvaginal Surgery Using ORIHIMEGynecology and minimally invasive therapyArticle
- The Prolapse Quality-of-life Questionnaire as a Substitute for Assessing Voiding and Storage Conditions in Patients Undergoing Transvaginal Mesh Surgery.Journal of mid-life healthArticle
- Device Selection Contributes to Operative Time Reduction in Laparoscopic Sacrocolpopexy.Gynecology and minimally invasive therapyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: This study aimed to evaluate the clinical outcomes and complications of transvaginal minimal mesh repair without using commercially available kits for treatment of pelvic organ prolapse (POP). Materials and Methods: This retrospective cohort study involved 91 women who underwent surgical management of POP with originally designed small mesh between July 2014 and August 2015. This mesh is 56% smaller than the mesh widely used in Japan, and it has only two arms delivered into each right and left sacrospinous ligament. The main study outcome was the anatomic cure rate defined as recurrence of POP quantification (POP-Q) stage II or more. We also assessed changes in the overactive bladder symptom score (OABSS) and prolapse quality of life questionnaire (P-QOL) and evaluated adverse events. Finally, we compared patient backgrounds between the patients with and without recurrence. Results: Prolapse recurred in 10 of 91 patients (11.0%), and all patients with recurrence were diagnosed as POP-Q stage II. As adverse events, only mesh erosion occurred in two (2.2%) and pelvic pain in one (1.1%) of the 91 patients. The OABSS and P-QOL were significantly improved by the operation. When we compared patient backgrounds between the patients with and without recurrence, body mass index was the only factor influencing affecting recurrence. Conclusions: Transvaginal minimal mesh repair resulted in successful outcomes with low mesh-related complications and anatomic recurrence at one year. Furthermore, significant improvement in QOL was offered by this procedure. Our minimal mesh technique should be considered as one treatment option for the management of POP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.